Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization

Slides:

Advertisements

Similar presentations

Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Peripheral Artery Disease: Evolving Role of Exercise,

Advertisements

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis Stavros Stavrakis, MD The American Journal.

Patients with abdominal aortic aneurysm: Are we missing the opportunity for cardiovascular risk reduction? G.M. Lloyd, MRCS, J.D. Newton, MRCP, M.G.A.

High Hemoglobin A1c Associated with Increased Adverse Limb Events in Peripheral Arterial Disease Patients Undergoing Revascularization Shipra Arya, Zachary.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population Mark R. Nehler, MD, Sue Duval, PhD, Lihong Diao,

Preoperative statin and diuretic use influence the presentation of patients undergoing carotid endarterectomy: Results of a large single-institution case-control.

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and.

Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: A subanalysis of the.

Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and.

Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes Thomas Mueller,

Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis Jana Ortmann, MD, Eveline Nüesch, PhD,

Smoking cessation is associated with decreased mortality and improved amputation- free survival among patients with symptomatic peripheral artery disease

Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease Scott E. Musicant, MD,

Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit Barry A. Franklin, PhD Mayo.

Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency,

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization

Frequency of cancer in patients operated on for acute peripheral arterial thrombosis and the impact on prognosis Chalotte Winther Nicolajsen, MD, Maja.

Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from.

Jack R. W. Brownrigg, MBChB, Michelle Griffin, MBChB, Cian O

Clinical factors associated with long-term mortality following vascular surgery: Outcomes from The Coronary Artery Revascularization Prophylaxis (CARP)

Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization Peter A. Soden, MD, Sara L. Zettervall, MD, MPH,

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Results of common femoral artery thromboendarterectomy evaluation of a traditional surgical management in the endovascular era Carola Marie Wieker, MD,

A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences Birgitta Sigvant,

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Jill.

Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency Jana Ortmann, MD, Brigitta Gahl, MD, Nicolas Diehm,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Michael C. Stoner, MD, Dorian J. deFreitas, MD, Sachin V

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A.

Michael S. Conte, MD Journal of Vascular Surgery

Mesenteric stenting for chronic mesenteric ischemia

Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial.

Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery George A. Antoniou, MD, PhD, MSc, FEBVS, Shahin.

Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia Yoshimitsu Soga, MD, Osamu Iida,

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Impact of diabetes on carotid artery revascularization

Mohammed Al-Omran, MD, MSc, Muhammad M

Katelynn M. Ferranti, MD, Turner M. Osler, MD, Reshma P

Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with.

Reshma P. Duffy, MD, Julie E. Adams, MD, Peter W

Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease Ehrin.

Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss Raghuveer Vallabhaneni,

Carla C. Moreira, MD, Alexander D

Outcomes of reinterventions after subintimal angioplasty

Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection Junichi Tazaki, MD, Takeshi Morimoto, MD, PhD, Ryuzo.

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

The use of machine learning for the identification of peripheral artery disease and future mortality risk Elsie Gyang Ross, MD, MSc, Nigam H. Shah, MBBS,

Long-term results of 442 consecutive, standardized carotid endarterectomy procedures in standard-risk and high-risk patients D. Preston Flanigan, MD,

Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal.

The EXercise versus Angioplasty in Claudication Trial (EXACT): Reasons for recruitment failure and the implications for research into and treatment of.

Abd Moain Abu Dabrh, MBBCh, MS, Mark W

Lower extremity arterial reconstruction for critical limb ischemia in diabetes Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai,

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic.

Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative Jeffrey J. Siracuse, MD, Matthew.

MATCH Results: Implications for the Internist

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Jon S. Matsumura, MD, Adnan Z. Rizvi, MD Journal of Vascular Surgery

The influence of polyvascular disease on the obesity paradox in vascular surgery patients Jan-Peter van Kuijk, MD, Willem-Jan Flu, MD, Wael Galal, MD,

Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease Esther Martinez-Aguilar, MD,

Sanne E. Hoeks, MSc, Wilma J

Jessica P. Simons, MD, MPH, Andres Schanzer, MD, Brian W

Reconstructive surgery for complex aortoiliac occlusive disease in young adults Enzo Ballotta, MD, Renata Lorenzetti, MD, Giacomo Piatto, MD, Francesca.

Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment Ralf W. Sprengers, MD, Martin Teraa,

Emily Spangler, Robert W. Chang, Philip P. Goodney

Francisco Alcocer, MD, Marjan Mujib, MD, Bruce Lowman, MD, Mark A

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy Andrea M. Steely, MD, Peter W.

Clinical outcomes after closed, staged, and open forefoot amputations

Presentation transcript:

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization Birgitta Sigvant, MD, PhD, Björn Kragsterman, MD, PhD, Mårten Falkenberg, MD, PhD, Pål Hasvold, MSc Pharm, Saga Johansson, MD, PhD, Marcus Thuresson, PhD, Joakim Nordanstig, MD, PhD Journal of Vascular Surgery Volume 64, Issue 4, Pages 1009-1017.e3 (October 2016) DOI: 10.1016/j.jvs.2016.03.429 Copyright © 2016 The Authors Terms and Conditions

Fig 1 Kaplan-Meier estimates of the risk of the primary composite end point (myocardial infarction, ischemic stroke, or cardiovascular [CV] death), all-cause mortality, and myocardial infarction and ischemic stroke after revascularization, separated by peripheral artery disease (PAD) stage. CI, Confidence interval; CVD, cardiovascular disease; HR, hazard ratio. Journal of Vascular Surgery 2016 64, 1009-1017.e3DOI: (10.1016/j.jvs.2016.03.429) Copyright © 2016 The Authors Terms and Conditions

Fig 2 Persistence to preventive drug treatment for intermittent claudication (IC) and critical limb ischemia (CLI). ACEi, Angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker. Journal of Vascular Surgery 2016 64, 1009-1017.e3DOI: (10.1016/j.jvs.2016.03.429) Copyright © 2016 The Authors Terms and Conditions

Fig 3 Time trends for best medical treatment (BMT; antiplatelet or anticoagulant therapy and statin treatment) 1 month after revascularization of claudication and critical lower limb ischemia patients. Journal of Vascular Surgery 2016 64, 1009-1017.e3DOI: (10.1016/j.jvs.2016.03.429) Copyright © 2016 The Authors Terms and Conditions

Supplementary Fig (online only) Age distribution for claudication and critical lower limb ischemia patients at admission for revascularization. Journal of Vascular Surgery 2016 64, 1009-1017.e3DOI: (10.1016/j.jvs.2016.03.429) Copyright © 2016 The Authors Terms and Conditions